AKEBIA THERAPEUTICS, INC. (AKBA) Return on equity 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-16.4%FY2025 · since FY2016: -199.3% → -16.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16.4% | — |
| FY2022 | -1801.6% | -1420.6 pp |
| FY2021 | -381.1% | -223.6 pp |
| FY2020 | -157.5% | -86.3 pp |
| FY2019 | -71.2% | -48.6 pp |
| FY2018 | -22.6% | +37.5 pp |
| FY2017 | -60.1% | +139.2 pp |
| FY2016 | -199.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AKBA financial trends
AKBA RevenueAKBA Net incomeAKBA Net marginAKBA Gross profitAKBA Gross marginAKBA Operating incomeAKBA Operating marginAKBA Operating cash flowAKBA Free cash flowAKBA Capital expendituresAKBA Stock buybacksAKBA Dividends paidAKBA Total assetsAKBA Total liabilitiesAKBA Shareholders’ equityAKBA overview →